State of the Diagnostic Industry: Recombinants on the Rise

In this June issue Thought Leader article, David A. George of Scripps Laboratories explains why recombinant technologies are the most responsible path to ensuring the continued availability of the tests patients and clinicians rely on every day. The post State of the Diagnostic Industry: Recombinants on the Rise appeared first on GEN - Genetic Engineering and Biotechnology News.